New Scientist6h
Do Ozempic and Wegovy really cause hair loss?
As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...
Alternative version of Ozempic, Wegovy may not be available much longer
Affordable and alternative versions of popular weight loss drugs like Ozempic and Wegovy may no longer be available. The FDA ...
Verywell Health on MSN8h
Contrave vs. Wegovy: How Do They Compare for Weight Loss?
Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
Popular weight-loss drug Wegovy receives approval in New Zealand
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its ...
Barclays cuts Novo Nordisk estimates on lower Wegovy, Ozempic volumes in the U.S.
Barclays has lowered its first-quarter 2025 estimates for Novo Nordisk (CSE:NOVOb) (NYSE:NVO) ahead of its Q1 2025 report, citing weaker-than-expected prescription volumes for key drugs Wegovy and ...
Costly GLP-1 drug use for wight loss has soared, study reports
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
The brutal Ozempic side effects celebs have been blighted by & those they WON’T admit to, from trout pouts to vomiting
WE’VE heard celebrities talk about the positives of Ozempic and other fat loss jabs – but there’s also a host of nasty side ...
Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform
(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its ...
I dropped 4 stone on fat jabs – people say it’s the ‘best glow-up’ they’ve seen but I had a very unexpected side effect
OLD has revealed that she lost over four stone after using Mounjaro for six months. Jasmine Hannah, a woman from the UK, ...
Hims & Hers to sell Lilly's Zepbound on its telehealth platform
Shares of the company were up 8.5% in afternoon trading. The telehealth firm is following its peers Teladoc and LifeMD in offering Lilly's Zepbound ahead of restrictions on selling copies known as ...
Becker's Hospital Review5h
GLP-1 spending hits $5.8B for adults without diabetes
A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 ...
Novo Nordisk shares post the biggest monthly decline since 2002
Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several ...